|
Oct 7
|
Nuvectis Pharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
|
|
Jul 28
|
Insiders hold 65% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and they've been buying recently
|
|
Mar 21
|
Insider Buys Additional US$51k In Nuvectis Pharma Stock
|
|
Feb 9
|
Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
|
|
Feb 9
|
Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
|
|
Dec 18
|
Nuvectis Pharma, Inc. Announces a Collaboration with Mayo Clinic to Evaluate NXP800 in an Investigator-Sponsored Clinical Trial in Cholangiocarcinoma
|
|
Sep 6
|
Nuvectis Pharma to Host KOL Event to Discuss Its Two Precision Medicine Clinical-Stage Drug Candidates, NXP800 and NXP900
|
|
Apr 27
|
Correction: Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
|
|
Apr 27
|
Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
|